Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma : DESCRIBE-AD real-world retrospective observational study
José L. Manzano, J. Martin-Liberal, Luis A. Fernández-Morales, G. Benítez, J. Medina Martínez, M. Quindós, A. García-Castaño, O. Fernández, R.V. Simo, Margarita Majem, L. Bellido, P. Ayala De Miguel, B. Campos, E. Espinosa, J.A. Macías Cerrolaza, I. Gil-Arnaiz, D. Lorente, A. Rodriguez-Lescure, V.N. Perez, R. López CastroM.G. Gramaje, T. Puértolas, J.F. Rodriguez Moreno, L. Espasa Font, G. Belaustegui Ferrández, P. Cerezuela-Fuentes
Dive into the research topics of 'Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma : DESCRIBE-AD real-world retrospective observational study'. Together they form a unique fingerprint.